Atypical Antipsychotic Agents, Retinopathy, Nephropathy, and Cardiovascular Disease

Diabetes Care - United States
doi 10.2337/dc06-0006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Pharmacoeconomic Comparison of Ziprasidone With Other Atypical Oral Antipsychotic Agents in Schizophrenia

Farmeconomia. Health economics and therapeutic pathways
2011English

Whole Transcriptome In-Silico Screening Implicates Cardiovascular and Infectious Disease in the Mechanism of Action Underlying Atypical Antipsychotic Side-Effects

2020English

Efficacy Should Drive Atypical Antipsychotic Treatment

BMJ
2003English

Chlorpromazine Versus Atypical Antipsychotic Drugs for Schizophrenia

2013English

Extrapyramidal Reactions From Concurrent SSRI and Atypical Antipsychotic Use

Irish Journal of Psychological Medicine
PsychiatryMental HealthPhilosophy of ScienceApplied PsychologyHistory
1998English

Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2007English

Comparative Cytochrome P450In VitroInhibition by Atypical Antipsychotic Drugs

ISRN Pharmacology
2013English

Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD

American Journal of Psychiatry
PsychiatryMental Health
2011English

Evidence for aSULT4A1haplotype Correlating With Baseline Psychopathology and Atypical Antipsychotic Response

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy